Internal Medicine, Hematology & Oncology · Fort Wayne, IN
NPI
1508835174
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
11050 Parkview Circle Dr
Fort Wayne, IN, 46845
Phone (833) 724-8326
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
1,008 services
Medicare patients, 2024
371
Average age 73
Drug cost, 2024
$14.3M
9,761 prescriptions
Company payments, 2025
$1,890
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert F Manges was code 99214 (office e&m - established), 657 times for 271 patients. In total Robert F Manges billed 1,008 services in 13 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 657 | 271 | $63.75 | $42K |
| 99231 Hospital E&M - Subsequent | Facility | 83 | 34 | $36.57 | $3,035 |
| 99232 Hospital E&M - Subsequent | Facility | 74 | 48 | $57.01 | $4,219 |
| 99204 Office E&M - New | Facility | 55 | 55 | $82.26 | $4,524 |
| 99214 Office E&M - Established | Office | 39 | 33 | $67.27 | $2,623 |
| 99213 Office E&M - Established | Facility | 27 | 24 | $41.67 | $1,125 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 23 | 16 | $11.76 | $270 |
| 99222 Hospital E&M - Initial | Facility | 20 | 15 | $96.51 | $1,930 |
By year: 2022 $80K for 1,026 services; 2023 $67K for 927 services; 2024 $62K for 1,008 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert F Manges prescribed most often to Medicare patients was Warfarin Sodium, with 6,753 prescriptions and refills. In total Robert F Manges wrote 9,761 Medicare prescriptions that cost $14.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Warfarin Sodium Generic | 6,753 | 17,653 | 1,913 | $55K |
| Jantoven Warfarin Sodium | 522 | 1,359 | 163 | $4,673 |
| Enoxaparin Sodium Generic | 277 | 277 | 160 | $29K |
| Eliquis Apixaban | 183 | 330 | 64 | $192K |
| Prochlorperazine Maleate Generic | 131 | 131 | 92 | $1,518 |
| Ondansetron Hcl Generic | 130 | 132 | 90 | $4,034 |
| Acyclovir Generic | 126 | 200 | 36 | $1,529 |
| Xarelto Rivaroxaban | 107 | 203 | 32 | $110K |
| Dexamethasone Generic | 101 | 111 | 65 | $1,806 |
| Tagrisso Osimertinib Mesylate | 99 | 99 | 12 | $1.6M |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 77 | 79 | 47 | $1,071 |
| Imbruvica Ibrutinib | 73 | 73 | Under 11 | $1.2M |
| Venclexta Venetoclax | 73 | 74 | 15 | $997K |
| Prednisone Generic | 55 | 61 | 28 | $217 |
| Hydroxyurea Generic | 51 | 91 | 11 | $650 |
Brand drugs: 1,088 claims; generic drugs: 8,673 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert F Manges $1,890 ($1,890 in general payments such as food, travel and fees) from 18 companies. The largest payer was Merck Sharp & Dohme LLC with $238.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 11 | $238 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $230 |
| Janssen Biotech, Inc. JNJ | 2 | $223 |
| Jazz Pharmaceuticals Inc. JAZZ | 7 | $216 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $166 |
| Genzyme Corporation SNY | 2 | $146 |
| Daiichi Sankyo Inc. 4568.T | 3 | $140 |
| Kite Pharma, Inc. GILD | 1 | $122 |
| Abbvie Inc. ABBV | 4 | $105 |
| Karyopharm Therapeutics Inc. KPTI | 4 | $79.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.